Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)

OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated summary by gemini-2.5-flash-lite+body, 2026-08-03

Three female patients experienced severe dysmenorrhea as their sole Familial Mediterranean Fever symptom, with elevated inflammatory markers and M694V mutations, responding to colchicine but not NSAIDs.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-30 · read from full text

This case report describes three female patients who presented with severe dysmenorrhea as the only symptom of Familial Mediterranean Fever, lacking typical fever or serositis. Laboratory tests revealed leukocytosis and elevated C-reactive protein during these attacks, which did not respond to non-steroidal anti-inflammatory drugs but resolved with colchicine treatment. The authors note that M694V mutations were frequent in these patients and emphasize that gynecologists should consider FMF in the differential diagnosis for dysmenorrhea, particularly in individuals of Mediterranean origin. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,273 characters · extracted from pmc-nxml · 1 sections · click to expand

Section

Familial Mediterranean Fever (FMF) is an autosomal recessive disease (MEFV gene) characterized by recurrent fever and inflammatory serositis. Although majority of patients have random pattern of attacks, some reports described precipitating factors. A literature review indicated that FMF attacks occurring only during menstruation are rarely seen. We report the cases of three patients with severe dysmenorrhoic pain as unusual clinical presentation of FMF. They were 3 females with a mean age at onset of 12 years. They never had typical attacks of fever and abdominal or chest pain, but they suffered from regular and severe dysmenorrhoic pain. Leukocytosis and C-reactive protein (CRP) elevation were noted during these attacks in all patients. Unlike dysmenorrhoea, none of these patients' attacks responded to non-steroidal anti-inflammatory drugs. The diagnosis of FMF was based on typical clinical and laboratory features. On investigation of MEFV, M694V was the most frequent mutation All patients responded well to colchicine, and amyloidosis was not documented in any patients. In conclusion, we suggest that gynecologists must be aware of FMF in the differential diagnosis of dysmenorrhoea or endometriosis especially in the people of Mediterranean origin.[ 1 ]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

dysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-20T09:27:46.357103+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0